ServicesMenopauseSame-Day Gynecology CareWeight Loss
Vaginal CareAbout UsFAQBlog
Get Started
Get Started
Home
/
The Menopause Notes
/

Estrogen Patch Shortage: What to Do Right Now

October 5, 2026

Estrogen Patch Shortage: What to Do Right Now

‍

If you've called three pharmacies this month looking for your estradiol patch, you're not the only one. The shortage is real, it's national, and it isn't close to over. Here's what's actually driving it, why Amazon Pharmacy is just as stuck as your corner CVS, and what our patients have done to stay covered.

‍

Why is there an estrogen shortage

‍

In November 2025, HHS and the FDA announced they were removing the decades-old "black box" warning from menopausal hormone therapy. The same label that had linked HRT to heart disease, breast cancer, and dementia risk since 2003. The FDA formalized that change in February 2026, striking the cardiovascular, breast cancer, and dementia warnings from six hormone therapy products. (The warning about endometrial cancer stays on estrogen-alone systemic products, for patients who still have a uterus.)

‍

That announcement changed prescribing almost overnight. Two decades of "don't start hormone therapy" training reversed in a single news cycle, and patients who'd been talked out of HRT, or talked themselves out of it, started asking for it again.

‍

The numbers show it. Estrogen patch prescriptions went from roughly 594,000 in June 2024 to 1.6 million in May 2026, according to HealthVerity data reported by CBS News — nearly tripling in under two years. The HRT Index tracker puts patch dispensing at more than triple its 2018 level as of February 2026, with prescribing among women 45–54 up 184%.

‍

‍

How patches actually get to CVS or Costco

‍

Estradiol patches don't go straight from the manufacturer to your pharmacy. They go from the manufacturer to a wholesaler, and the wholesaler ships to retail chains and mail-order pharmacies based on existing contracts and each pharmacy's historical order volume. When a manufacturer can't produce enough, it doesn't split the shortfall evenly, but it rations what it has among the customers it already supplies. Zydus, one of the affected generic manufacturers, is "rationing to existing contracted customers" rather than filling new or larger orders.

‍

CVS Health has said as much publicly: manufacturers "have been unable to deliver sufficient quantities" of hormone therapy products in recent weeks. That's a manufacturing problem sitting upstream of every pharmacy counter. It isn't that CVS or Costco is managing inventory badly.

‍

Not every patch is affected equally. The twice-weekly patches (Vivelle-Dot, Minivelle, Climara, Dotti) have taken the biggest hit, while once-weekly patches from Bayer, Viatris/Mylan, and Sandoz have stayed more available. If your pharmacy is out, it's worth asking your clinician whether a once-weekly product is a reasonable switch.

‍

‍

Demand is climbing, and this will probably get worse before it gets better

‍

This isn't a short supply blip. A Sandoz spokesperson told Reuters: "When the FDA removed the safety warning in November, it created unprecedented demand that cannot fully be met at present." Reuters reported that industry sources expect the shortage to last up to three years.

‍

‍

Amazon and the big mail-order pharmacies are just as squeezed

‍

Switching to mail order doesn't automatically fix this. Amazon Pharmacy has been messaging customers directly about it: "This medication may be periodically unavailable until this shortage is resolved... We apologize that your order is impacted by this industry-wide shortage." Cost Plus Drugs has reported longer waits for the same reason. This is a manufacturing bottleneck, not a retailer problem, so moving your prescription from one big pharmacy to another big pharmacy often just moves you to a different waitlist.

‍

‍

Pharmacies that have worked for our patients

‍

A few places our patients have had better luck filling patches:

‍

  • Pandia Health — telehealth platform that also dispenses menopause medications directly.
  • The HRT Club — telehealth-focused pharmacy built specifically around hormone therapy. Worth knowing: Reuters reported HRT Club's own patch sales rose 150% after the November FDA announcement, so their supply can tighten too. However, our patients have had more consistent luck here than with big chains.
  • Calling around, the unglamorous way. Independent and small regional pharmacies are worth a phone call even if you've never used one. They're not always checked by the apps that show "in stock" at chains. Ask the pharmacist directly whether they can check other locations in their system, and ask your clinician's office if they're tracking which local pharmacies currently have supply; many practices are now keeping an informal running list.

‍

If your patch still isn't available

‍

A few alternatives are worth discussing with your clinician rather than going without estrogen while you wait:

‍

  • Estrogen gel (EstroGel, Divigel, Elestrin) delivers the same hormone daily instead of twice weekly. We're seeing tightening supply on gel too in recent weeks, so don't assume it's a guaranteed fallback. Call ahead before you switch.
  • Evamist is a metered-dose estradiol spray applied to the inner forearm. It's a different manufacturing pipeline than the patches, so it's sometimes in stock when patches aren't.
  • Oral estrogen pills remain a safe, effective option for many patients, and they're widely available. They're not the right fit for everyone (a history of blood clots or migraine with neurological changes are reasons to think twice about oral estrogen specifically) but for patients without those risk factors, a pill is a reasonable bridge, and for some, a reasonable long-term choice.

‍

The point isn't to pick one of these on your own. It's to have the conversation with your clinician now, before you're down to your last patch, so the switch is planned instead of a scramble.

‍

Common questions

‍

Is this shortage really nationwide, or just certain regions? National. Reporting from CBS, NBC, Reuters, and pharmacy-tracking sites all describe it as a coast-to-coast supply problem, not a regional one.

‍

Will insurance cover a switch to gel, Evamist, or pills? Usually, but coverage and prior authorization rules vary by plan and by which product you're switching to. Check with your pharmacy or insurer before you assume a switch is a straight swap.

‍

Should I stockpile patches if I find some in stock? Fill what your prescription and insurance allow, but don't ask a pharmacy to sell you more than that. It worsens the shortage for everyone else looking for the same box.

‍

How long will this actually last? Nobody can say with certainty, but we don’t see the supply issue being fixed rapidly and a rising demand.

Want to Talk Through What You're Experiencing?

‍

Book a free 15-minute intro call with Gliss Wellness — no referral, no waiting room, just a real conversation with an OB/GYN. Click here to get started.

‍

‍

Sources

‍

‍

hormone therapy
/
Estrogen Patch Shortage: What to Do Right Now
Estradiol patches are back-ordered at pharmacies nationwide, and it's not letting up. OBGYN Dr. Diana Kumar explains why it happened, which pharmacies still have supply, and what to switch to if yours doesn't.
vaginal health
/
Desquamative Inflammatory Vaginitis: The Burning Nobody Diagnoses
Yellow-green discharge, burning, no odor, and every infection test negative? DIV is a real, treatable condition that most women are never tested for. Dr. Kumar explains how it's diagnosed.
vaginal health
/
Burning After Sex but All My Tests Were Normal
Negative swabs don't mean nothing is wrong. Dr. Kumar walks you through the causes of post-sex burning that standard infection testing can't detect, and what to ask for instead.

Real Talk, No Filter

Join our newsletter, where we talk about perimenopause, hormones, sexual health, and everything else!